[1] ZHENG R, ZHANG S, ZENG H, et al.Cancer incidence and mortality in China, 2016[J]. Journal of the National Cancer Center, 2022, 2(1): 1-9. [2] TRAVIS WD, BRAMBILLA E, BURKE AP, et al.Introduction to The 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart[J]. J THORAC ONCOL, 2015, 10(9): 1240-1242. [3] TORRE LA, SIEGEL RL, JEMAL A.Lung cancer statistics[J]. ADV EXP MED BIOL, 2016, 893: 1-19. [4] PETERSEN I, WARTH A.Lung cancer: developments, concepts, and specific aspects of the new WHO classification[J]. J Cancer Res Clin, 2016, 142(5): 895-904. [5] WU K, HOUSE L, LIU W, et al.Personalized targeted therapy for lung cancer[J]. International Journal of Molecular Sciences, 2012, 13(9): 11471-11496. [6] KANG LF, ZHENG J, ZHU X.Relationship between EGFR mutations and pathological classification and specimen of lung adenocarcinoma[J]. Chinese Journal of Lung Cancer(中国肺癌杂志), 2017, 20(6): 382-388. [7] LU MQ, DOU PH, WANG Z, et al.Clinical research progress of osimertinib[J]. Guangdong Chemical Industry(广东化工), 2023, 50(6): 82-84. [8] DU FH, MIN XH, MEI XD.Application and drug resistance mechanism of targeted therapy drugs for adenocarcinoma of the lung[J]. Journal of Clinical Pulmonary Medicine(临床肺科杂志), 2018, 23(1): 168-172. [9] XIE YG, SHEN KP, LU YL.Research progress in the treatment of non-small cell lung cancer with traditional Chinese medicine[J]. Chinese Journal of Traditional Chinese Medicine(中华中医药杂志), 2021, 36(5): 2846-2851. [10] XIONG Q, YAN ZA, XIANG RQ, et al.Research progress on the mechanism of active ingredient of traditional Chinese medicine in the treatment of lung cancer[J]. Journal of Liaoning University of Traditional Chinese Medicine(辽宁中医药大学学报), 2023: 1-19. [11] ZHANG XW, LIU W, JIANG HL, et al.Chinese herbal medicine for advanced non-small-cell Lung cancer: a systematic review and meta-analysis[J]. AM J Chinese Med, 2018, 46(5): 923-952. [12] ZHANG R, WANG XZ, WANG JJ, et al.Review of computational methods for predicting drug target interactions[J]. Computer Engineering and Application(计算机工程与应用), 2023: 1-16. [13] DUAN AX, CHEN J, LIU HD, et al.Application and development of macromolecular docking methods[J]. Journal of Analytical Sciences(分析科学学报), 2009, 25(4): 473-477. [14] LI Y, LI DK, LI KM, et al.Screening of anthraquinone Farnesyltransferase inhibitors in Reynoutria multiflora based on molecular simulation technology[J]. Chinese Journal of New Drugs(中国新药杂志), 2018, 27(18): 2164-2172. [15] LI Y, JIANG LD, CHEN Q, et al.Research on the discovery of antihypertensive components of traditional Chinese medicine based on the opening of potassium Ion channel[J]. Chinese Journal of Traditional Chinese Medicine(中国中药杂志), 2016, 41(2): 264-271. [16] HU YH, LI DK, QUAN ZY, et al.Exploration of components and mechanisms of polygoni multiflori radix-induced hepatotoxicity using siRNA -mediated CYP3A4 or UGT1A1 knockdown liver cells[J]. J Ethnopharmacol, 2021, 270: 113845. [17] CHOU TC.Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies[J]. Pharmacol Rev, 2006, 58(3): 621-681. [18] HOLBRO T, CIVENNI G, HYNES NE.The ErbB receptors and their role in cancer progression[J]. Exp Cell Res, 2003, 284(1): 99-110. [19] National Pharmacopoeia Commission.Pharmacopoeia of the China: Volume I, Version 2020 (中华人民共和国药典一部)[S]中华人民共和国药典一部)[S]. Beijing: China Medical Science Press, 2020: 177. [20] ZHONG YF, LEI LS, YU CL, et al.Effect of aqueous extract of Forsythia suspensa on proliferation of S180 tumor cells and Splenocyte in vitro[J]. Journal of Guangdong University of Pharmacy(广东药学院学报), 2009, 25(2): 184-187. [21] HU WJ, QIAN XP, TU YX, et al.Experimental study on the anti-tumor effect of ethanol extract from Forsythia suspensa[J]. Journal of Nanjing University of Chinese Medicine(南京中医药大学学报), 2007(6): 379-381. [22] XU P, SUN J, HU WJ, et al.Effects of ethanol extract from Forsythia suspensa on proliferation and apoptosis of human gastric cancer cell lines BGC-823[J]. Journal of Medical Graduate Students(医学研究生学报), 2007(12): 1235-1238. [23] HUANG HL, JIANG WL, HSIAO PC, et al.Timosaponin AIII mediates caspase activation and induces apoptosis through JNK1/2 pathway in human promyelocytic leukemia cells[J]. Tumour Biol, 2015, 36(5): 3489-3497. [24] WANG N, FENG Y, ZHU M, et al.A novel mechanism of XIAP degradation induced by timosaponin AIII in hepatocellular carcinoma[J]. Biochim Biophys Acta, 2013, 1833(12): 2890-2899. [25] CAO S, YAN XY, MA J, et al.SAaB inhibits lung cancer proliferation and stem cell formation by regulating the hedgehog signaling pathway mediated SOX2[J]. Research on Cancer Prevention and Treatment(肿瘤防治研究), 2020, 47(8): 590-595. |